Delivery Order 36F79720D0237-36C26221F0262
Award Date 5/1/21
Potential Completion Date 5/6/21
Potential Value $39K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Dublin, OH 43017, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 awarded a $73,237.96 firm fixed price delivery order to Bayer Healthcare Pharmaceuticals Inc. for XOFIGO RA-223 dichloride dose under the Pharmaceuticals and Drugs (FSS-61-IB) GSA Schedule. The delivery order was awarded on October 22, 2020 with a completion date of July 1, 2021. No set-aside designation was used for this contract. Performance will take place in Dublin, Ohio. The contract...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 awarded Bayer Healthcare Pharmaceuticals Inc. a $12,750.44 firm fixed price delivery order for radiopharmaceutical Xofigo under the Pharmaceuticals and Drugs (FSS-61-IB) GSA Schedule. Performance will take place in Dublin, Ohio through November 30th, 2022. No set-aside designation was used for this order. Bayer Healthcare Pharmaceuticals Inc., operating as Bayer Healthcare Pharmaceuticals Inc....
- The Department of Veterans Affairs Veterans Health Administration awarded a $174,032.92 delivery order contract to Bayer Healthcare Pharmaceuticals Inc. for the drug XOFIGO. As the prime contractor, Bayer Healthcare Pharmaceuticals Inc. will supply the pharmaceutical to Veterans Integrated Service Network 20 in accordance with the firm fixed price terms of the contract. The award utilizes Bayer AG Pharmaceuticals Division's Pharmaceuticals and Drugs GSA Schedule 61-IB, a multiple award vehicle...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 10 awarded a $85,020.71 delivery order to Bayer Healthcare Pharmaceuticals Inc. for the pharmaceutical RADIUM-223 XOFIGO. The delivery order was issued against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) master contract and carries a firm fixed price. Performance will take place in Whippany, New Jersey, with completion by January 2, 2025. Bayer Healthcare Pharmaceuticals...
- This is a delivery order awarded to Bayer Healthcare Pharmaceuticals Inc. under the Department of Veterans Affairs (VA) Veterans Health Administration's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract. The order is for the delivery of XOFIGO RADIUM, a prostate cancer treatment drug, to the VA's Veterans Integrated Service Network 4 in Dublin, Ohio. The firm fixed price contract has a potential value of $107,703.84 and a completion date of May 8, 2020. No small business...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20 awarded a $118,399.96 firm fixed price delivery order to Bayer Healthcare Pharmaceuticals Inc. for XOFIGO (RA-223 DICHLORIDE INJECTION) under the Pharmaceuticals and Drugs (FSS-61-IB) GSA Schedule. Performance will take place in Whippany, New Jersey, with a completion date of December 29, 2021. No set-aside designation was used for this contract. Bayer Healthcare Pharmaceuticals Inc. will...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 awarded a $55,476.47 delivery order to Bayer Healthcare Pharmaceuticals Inc. for 851 doses of the brand name oncology drug Xofigo, also known as radium Ra 223 dichloride, to be provided to Loma Linda Nuclear Medicine by September 30, 2023. The delivery order was issued against Bayer Healthcare Pharmaceuticals Inc.'s Pharmaceuticals and Drugs Federal Supply Schedule contract, referred to as...
- This is a federal contract award to Bayer Healthcare Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company, for the delivery of XOFIGO, a specialized radiopharmaceutical product for the treatment of prostate cancer. The contract, valued at $90,214.74, was awarded by the Department of Veterans Affairs (VA) on October 23, 2019, with a completion date of May 31, 2020. The contract is a delivery order under the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB),...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded a $10,694.33 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule contract to Bayer Healthcare Pharmaceuticals Inc. for the drug XOFIGO (radium Ra 223 dichloride injection). Performance will occur in Whippany, New Jersey by April 2023. Bayer Healthcare Pharmaceuticals Inc. is a division of Bayer AG. The delivery order was awarded on a firm fixed price basis...
- Bayer Healthcare Pharmaceuticals Inc., a subsidiary of Bayer AG focused on pharmaceutical research and marketing, has been awarded a $177,199.13 delivery order for XOFIGO GLA by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22. The delivery order was issued under Bayer's multiple award schedule contract for pharmaceuticals and drugs, referred to as FSS-61-IB, with the work being performed in Dublin, OH. No set aside designation was...